Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats.

Rezvani AH, Cauley MC, Johnson EC, Gatto GJ, Levin ED.

Psychopharmacology (Berl). 2012 Oct;223(3):251-8. doi: 10.1007/s00213-012-2712-2. Epub 2012 Apr 20.

PMID:
22526540
2.

Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.

Rezvani AH, Cauley M, Sexton H, Xiao Y, Brown ML, Paige MA, McDowell BE, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2011 Jun;215(4):621-30. doi: 10.1007/s00213-010-2161-8. Epub 2011 Jan 28.

PMID:
21274704
3.
4.

Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.

Rezvani AH, Tizabi Y, Getachew B, Hauser SR, Caldwell DP, Hunter C, Levin ED.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1030-40. doi: 10.1016/j.pnpbp.2008.01.018. Epub 2008 Feb 12.

PMID:
18343006
5.

Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats.

Rezvani AH, Cauley M, Xiao Y, Kellar KJ, Levin ED.

Psychopharmacology (Berl). 2013 Mar;226(1):35-43. doi: 10.1007/s00213-012-2895-6. Epub 2012 Oct 26.

PMID:
23100170
6.

Improvement of attentional function with antagonism of nicotinic receptors in female rats.

Levin ED, Cauley M, Rezvani AH.

Eur J Pharmacol. 2013 Feb 28;702(1-3):269-74. doi: 10.1016/j.ejphar.2013.01.056. Epub 2013 Feb 8.

7.

Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.

Rezvani AH, Kholdebarin E, Dawson E, Levin ED.

Int J Neuropsychopharmacol. 2008 Feb;11(1):63-70. Epub 2007 Feb 13.

PMID:
17295931
8.

Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats.

Burke DA, Heshmati P, Kholdebarin E, Levin ED.

Eur J Pharmacol. 2014 Oct 15;741:132-9. doi: 10.1016/j.ejphar.2014.07.030. Epub 2014 Jul 24.

9.

Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.

Rezvani AH, Kholdebarin E, Cauley MC, Dawson E, Levin ED.

Pharmacol Biochem Behav. 2009 Mar;92(1):141-6. doi: 10.1016/j.pbb.2008.11.005. Epub 2008 Nov 17.

PMID:
19041337
10.

Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.

Levin ED, Petro A, Caldwell DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):581-6.

PMID:
15866361
11.

Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine.

Timofeeva OA, Levin ED.

Pharmacol Biochem Behav. 2008 Sep;90(3):372-81. doi: 10.1016/j.pbb.2008.03.011. Epub 2008 Mar 27.

PMID:
18456310
12.

Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.

Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B.

Brain Res. 2005 Apr 18;1041(2):132-42.

PMID:
15829222
13.

Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism.

Rasmussen BA, Perry DC, O'Neil J, Manaye KF, Tizabi Y.

Neurotox Res. 2008 May-Jun;13(3-4):151-61.

PMID:
18522895
14.

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.

Dunbar G, Boeijinga PH, Demazières A, Cisterni C, Kuchibhatla R, Wesnes K, Luthringer R.

Psychopharmacology (Berl). 2007 May;191(4):919-29. Epub 2007 Jan 16.

PMID:
17225162
15.

AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adults.

Potter AS, Dunbar G, Mazzulla E, Hosford D, Newhouse PA.

Biol Psychiatry. 2014 Feb 1;75(3):207-14. doi: 10.1016/j.biopsych.2013.06.002. Epub 2013 Jul 12.

PMID:
23856296
16.

Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.

Roncarati R, Scali C, Comery TA, Grauer SM, Aschmi S, Bothmann H, Jow B, Kowal D, Gianfriddo M, Kelley C, Zanelli U, Ghiron C, Haydar S, Dunlop J, Terstappen GC.

J Pharmacol Exp Ther. 2009 May;329(2):459-68. doi: 10.1124/jpet.108.150094. Epub 2009 Feb 17.

17.

Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.

Callahan PM, Terry AV Jr, Tehim A.

Psychopharmacology (Berl). 2014 Sep;231(18):3695-706. doi: 10.1007/s00213-014-3509-2. Epub 2014 Mar 5.

18.

The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.

Cannon CE, Puri V, Vivian JA, Egbertson MS, Eddins D, Uslaner JM.

Neuropharmacology. 2013 Jan;64:191-6. doi: 10.1016/j.neuropharm.2012.05.003. Epub 2012 May 29.

PMID:
22659472
19.

Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.

Kholdebarin E, Caldwell DP, Blackwelder WP, Kao M, Christopher NC, Levin ED.

Eur J Pharmacol. 2007 Aug 13;569(1-2):64-9. Epub 2007 May 22.

20.

Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats.

Levin ED, Hao I, Burke DA, Cauley M, Hall BJ, Rezvani AH.

J Psychopharmacol. 2014 Oct;28(10):915-22. doi: 10.1177/0269881114543721. Epub 2014 Aug 13.

Supplemental Content

Support Center